News

Weekly Policy Update: The Colorado Experience, Tariff Advocacy, and FDA Funding News

Friday, May 25, 2018

COLORADO EXPERIENCE – BOULDER

 
Continue Reading

Weekly Policy Update: A Quick Review of President Trump’s Prescription Medication Plan

Friday, May 18, 2018


 

Just-Released Economic Data Finds Improving Education in Colorado Would Generate Billions for the Economy

Tuesday, May 15, 2018


 
Continue Reading

Weekly Policy Update: The Close of the Second Regular Session and Unveiling Federal Drug Price Policies

Friday, May 11, 2018

 

Coming Together as a Community

Tuesday, May 08, 2018

 

Gates Biomanufacturing Facility readies first shipment of clinical trial cancer treatments

Monday, May 07, 2018

Groundbreaking moment represents years of planning, training and biomedical expertise 
Continue Reading

Weekly Policy Update: Industry Defeats Harmful Transparency Measures at the Capitol

Friday, May 04, 2018

CBSA had a busy legislative session advocating on behalf the industry against transparency measures that stood to stifle bioscience innovation in Colorado and failed to provide the relief patients need next time they pick up a prescription or schedule a procedure. On behalf of the Colorado BioScience Association, our members, and the bioscience industry, we thank the Colorado General Assembly and those leaders who opposed the harmful transparency measures.